Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. (Q39828324)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

renal cell carcinoma

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Daniel P Stiehl

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

K Balamurugan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V-D Luu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M R Kaufmann

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

V S Hofmann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Barth

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M R Bordoli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

H Moch

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

P Schraml

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

R H Wenger

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

G Camenisch

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

0 references

publication date

6 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

3274-3285

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19581925%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

https://scigraph.springernature.com/pub.10.1038/onc.2009.186

0 references

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Paraneoplastic neurological degenerations: keys to tumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Exploiting tumour hypoxia in cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

A conserved family of prolyl-4-hydroxylases that modify HIF

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Asparaginyl hydroxylation of the Notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Paraneoplastic Syndromes Involving the Nervous System

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

ASB4 is a hydroxylation substrate of FIH and promotes vascular differentiation via an oxygen-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Genetic progression of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Histological features of hypovascular or avascular renal cell carcinoma: the experience at four university hospitals

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF).

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Hypoxia signalling in cancer and approaches to enforce tumour regression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

A T-cell receptor associated with naturally occurring human tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Oxygen sensing by HIF hydroxylases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Suppression of hypoxia-inducible factor 1alpha (HIF-1alpha) transcriptional activity by the HIF prolyl hydroxylase EGLN1

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Integration of oxygen signaling at the consensus HRE.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

21 January 2018

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1alpha.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

A post-transcriptional regulatory mechanism restricts expression of the paraneoplastic cerebellar degeneration antigen cdr2 to immune privileged tissues

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Observing the invisible: successful tumor immunity in humans

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

The Heidelberg classification of renal cell tumours.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Unexplained spontaneous regression and alpha-interferon as treatment for metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Activation of Hypoxia-inducible Factor-1; Definition of Regulatory Domains within the α Subunit

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Spontaneous regression of histologically proved pulmonary metastases from renal cell carcinoma: a case with 5-year followup

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.186

31 March 2020

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39828324&oldid=2091052909"